🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 800677106
- Market Cap
- Small Cap
- IPO
- 4/6/2000 · $15.00/share
Business: Sangamo is a clinical stage biopharmaceutical company focused on the research, development and commercialization of engineered DNA-binding proteins as novel therapeutics to treat unmet medical needs. They are worldwide leaders in developing zinc finger DNA-binding proteins (ZFPs) for therapeutic gene regulation and modification. Their ZFP technology platform has multiple applications in: Human Therapeutics, High-value Research Tools, Transgenic Animals, Cell-line Engineering for Protein Manufacturing, Plant Agriculture.
Company Contact
- CEO
- Sandy Macrae
- CFO
- Prathyusha Duraibabu
- Headquarters
- 7000 Marina Blvd., Brisbane, CA 94005
- Phone
- 510-970-6000
- Investor Relations
- Louise Wilkie · 628-252-7840 · IR@sangamo.com